CounterAct offers first UV tech safe to use around people
The McMorrow Reports
October 15, 2022
As we prepare for a post-pandemic world where reducing pathogens and viral spread is essential, Christie announced the mass production of its Christie CounterAct line of commercial UV disinfection products with patented Care222 far-UVC light technology. CounterAct fixtures are designed for use in occupied indoor spaces, from cinemas, theme parks, museums, and sports complexes, to retail, restaurants, as well as transit hubs at airports, train and subway stations.